InMed, a publicly traded company, receives a Nasdaq deficiency notice related to an equity requirement, according to reporting from Investing.com and Seeking Alpha. The notice indicates the company is not in compliance with a Nasdaq listing rule tied to equity levels.
The articles describe the notification process but do not, in the provided excerpts, specify the full rule citation, the exact equity threshold, or the timing for a cure. Both outlets frame the development as a compliance matter that could affect the company’s continued listing if not resolved within Nasdaq’s remediation timeline.
Across the two reports, the shared focus is the same: InMed is formally alerted by Nasdaq for falling short of a requirement related to equity. Any differences between the outlets would likely concern details such as the specific deficiency type or the company’s stated next steps; those specifics are not included in the text supplied here. Overall, the coverage aligns on the existence of the Nasdaq notice and its connection to equity compliance.
